Petrie-Flom Welcomes New Executive Director!

Petrie-Flom Center, May 10, 2017

We are thrilled to announce that Carmel Shachar, JD, MPH (HLS ’10, HSPH ’10), will join the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School…

Read More

Turning to the States to Solve the National Problem of Drug Pricing

STAT News, June 20, 2017
Meghana Keshavan, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: Drug pricing is a national problem. So a nonprofit wants to help hand off some of that burden to the states. The National Academy for State Health Policy just launched a new center, called the Center for State Rx Drug Pricing, to help state governments navigate the…

Read More

Is Competition the Solution to High Drug Prices?

Marketplace, June 14, 2017
Dan Gorenstein, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: “Biosimilars free up funding in the health care system to pay for other innovations,” Howard said. “So there is that breathing space that generic competition creates in the market.” …

Read More

Trying to Keep up with the Health Care Debate on the Hill? Follow These Folks on Twitter

STAT News, June 13, 2017
Megha Satyanarayana, featuring Rachel E. Sachs (Academic Fellow Alumna)

From the article: The GOP effort to repeal and replace Obamacare is picking up steam again as the Senate works on its bill behind closed doors. How to keep track of it all? Here are a few folks to follow on Twitter: …

Read More

This Pharma Company Won’t Commit to Fairly Pricing a Zika Vaccine You Helped Pay For

The Huffington Post, June 9, 2017
Alexander C. Kaufman, quoting Rachel E. Sachs (Academic Fellow Alumna)

From the article: “The incentives for any one company to raise its prices or engage in questionable conduct are quite high, while the incentives for the industry as a whole to corral and police its members are really quite difficult…

Read More

PFC Spotlight: Academic Fellow Alumnus Jeffrey Skopek

Petrie-Flom Center, June 15, 2017
Petrie-Flom Center

Jeffrey Skopek was an Academic Fellow for the 2011-2014 academic years, during which he wrote extensively on anonymity, differentiating it from…

Read More

Q&A with Faculty Scholar Rachel Sachs

Institute for Public Health at Washington University , May 23, 2017
Interview featuring Rachel Sachs (Academic Fellow Alumna)

From the interview: Rachel Sachs, associate professor, School of Law, is a scholar of innovation policy whose work explores the interaction of intellectual property law, food and drug regulation, and health law and identifies potential problems and solutions…

Read More

How a Supreme Court ruling on printer cartridges could have a big impact on drug prices

STAT News, May 30, 2017
Meghana Keshavan, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: A Supreme Court ruling on international printer cartridge sales could have major implications for, of all things, drug pricing and global health. The case in question involves patents, crucial legal protections for…

Read More

Legal Roundtable: Discussing abortion restrictions, health care, Supreme Court developments and more

St. Louis Public Radio, May 30, 2017
Kelly Moffitt, featuring Rachel Sachs (Academic Fellow Alumna)

From the radio episode: On Tuesday’s St. Louis on the Air, Legal Roundtable panel returned to discuss pressing issues of the law. They discussed a number of topics, starting with national issues of government leaks, the Supreme Court, and President Trump's…

Read More

The Sean Pendergast Show with Dr. Glenn Cohen, Harvard Law Professor

The TJ Show, AMP Radio 103.3 FM, May 28, 2017
Interviewing I. Glenn Cohen (Faculty Director)

Harvard Law Professor [I. Glenn Cohen (Faculty Director)] joins Sean to discuss a study he and a Harvard group did on player…

Read More

Reading the Fine Print in DNA Kits

NBC Boston, May 23, 2017
Interview featuring I. Glenn Cohen (Faculty Director)

DNA kits are very popular these days with people wanting to know what countries their ancestors came from. But before seeking out the secrets of your family tree, make sure you read the fine print. Watch the interview here!

Read More

Roster exemptions for players with concussions could draw vote from NFL owners

USA Today, May 22, 2017
Tom Pelissero, citing Petrie-Flom's report

From the article: A short-term injured reserve for players diagnosed with a concussion was among 76 recommendations included in a Harvard Law School report — based on research funded by the NFL Players Association and published in November — that also…

Read More

Why Successful Post-Season Runs Make People Lose Their Minds About Concussions

Forbes, May 16, 2017
Lee Igel, citing Petrie-Flom's report

From the article: Were either or both Crosby and Harden suffering the effects of a head injury, yet seeing game action? Appearances can be deceiving. In addition to medical personnel assessing a player's sense of balance and awareness, part of concussion diagnosis…

Read More

How does the NFL stack up with health care?

ESPN, May 22, 2017
Michael McCann, citing Petrie-Flom's report

Sports Illustrated legal analyst Michael McCann joins OTL to discuss the NFL's health care for its players. Watch video here!

Read More

Angel investors are the first stop in a new era of drug development

Newsworks, May 11, 2017
Elana Gordon, quoting Rachel Sachs

From the article: So is this really the best way to develop new healthcare technologies and therapies? "So there are pros and there are cons," said Rachel Sachs, a law professor at Washington University in St. Louis who…

Read More

The Trump administration could bring down drug prices. But it would take guts

STAT News, May 15, 2017
Ed Silverman, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: “If Price and [President] Trump are interested in lower-priced drugs, they have access to a tool that enables them to do that,” explained Rachel Sachs, an associate professor at the Washington University School of Law who participated…

Read More

The White House budget director dropped a hint about how Trump could bring drug prices down

Washington Post, May 12, 2017
Carolyn Y. Johnson, quoting Rachel Sachs (Academic Fellow Alumna)

From the artcile: Trump has repeatedly said that drug prices are too high but has often suggested that increased bidding would be the best way to bring down prices. It has been unclear how that would work or whether Congress would support it. Mulvaney appeared…

Read More

New FDA Chief Scott Gottlieb: Medication Reformer or Big Pharma Shill?

The Fix, May 18, 2017
Paul Gaita, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: Gottlieb's position has earned cautious approval from medical industry observers like Washington University associate professor Rachel Sachs, who wrote, "As someone who understands the drug development process from all sides, [Gottlieb] will…

Read More

New York state wants its prescription drug money back—or else

USA Today, May 18, 2017
Julie Appleby, quoting Rachel Sachs (Academic Fellow Alumna)

From the article: New York’s Medicaid program, for example, has seen its drug spending rise on average 8% each year over the past three years, after taking into account existing rebates. The program, which uses federal and state funds, serves more than…

Read More

Faculty Books in Brief—Spring 2017

Harvard Law Bulletin, May 18, 2017
Featuring book by I. Glenn Cohen (Faculty Director), Holly Fernandez Lynch (Executive Director), & Christopher T. Robertson (Academic Fellow Alumnus)

From the article: Cohen, faculty director of the Petrie-Flom Center; Lynch, the center’s executive director; and Robertson, a professor at University of Arizona’s College of Law, edit essays that focus on how health law and policy can—or should—use…

Read More